Apixaban
Top View
- NON-INTERVENTIONAL (NI) STUDY PROTOCOL Post
- COVID-19 Vaccine Astrazeneca (Other Viral Vaccines) EPITT No:19683
- Inclusions and Exclusions for IV
- Eliquis (Apixaban)
- Eliquis 2.5 Mg Film-Coated Tablets
- Managing New Oral Anticoagulants in the Perioperative and Intensive
- Treatment with Apixaban | Eliquis |
- ELIQUIS Product Monograph
- Switching from Warfarin to ELIQUIS® (Apixaban) Patient Information Booklet
- Guidance on Safe Switching of Warfarin to DOAC
- Prescriptions of Direct Oral Anticoagulants in Patients Admitted
- Quantification of Apixaban in Human Plasma Using Ultra Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry
- Rivaroxaban and Apixaban for DVTVTE Prophylaxis
- Apixaban) Tablets
- Anti-Platelet and Anti-Coagulant Prescriptions and Breast Cancer Recurrence: a Danish Nationwide Prospective Cohort Study
- Comparison of New Anticoagulants to Warfarin and Low-Molecular-Weight Heparin
- ELIQUIS Safely and Effectively
- Which Direct Oral Anticoagulant (DOAC) Is Best for My Patient?